Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21152875rdf:typepubmed:Citationlld:pubmed
pubmed-article:21152875lifeskim:mentionsumls-concept:C0021344lld:lifeskim
pubmed-article:21152875lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:21152875lifeskim:mentionsumls-concept:C0005684lld:lifeskim
pubmed-article:21152875lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:21152875lifeskim:mentionsumls-concept:C0205281lld:lifeskim
pubmed-article:21152875lifeskim:mentionsumls-concept:C0031928lld:lifeskim
pubmed-article:21152875pubmed:issue2lld:pubmed
pubmed-article:21152875pubmed:dateCreated2010-12-24lld:pubmed
pubmed-article:21152875pubmed:abstractTextThe relationship between urothelial bladder cancer and high-risk human papillomaviruses (HR-HPV) is still a poorly understood entity, even if some studies have supposed a probably correlation. The aim of the present study was to assess the potential relationship between the presence of HR-HPV and non-muscle invasive urothelial bladder cancers (NMIBC). One hundred and thirty-seven subjects (78 patients affected by NMIBC and 59 controls) were recruited in this prospective study. HR-HPV DNA was evaluated both in urine and tumour tissues. Data from patients were compared with data from controls. The relationship between patients and controls, in terms of HR-HPV presence was performed. The relationship between all pathological data and HR-HPV presence in patient group was carried out. HR-HPV DNA in tissue was found in 27 of 78 (34.6%) tumour samples and in 6 of 59 (10.1%) specimens from TUR-P, with a statistically significant difference (p=0.0009; dF=1; ?2=10.98). HR-HPV DNA in urine was found in 36 of 78 (46.1%) samples obtained from patients, whereas in only 8 of 59 (13.5%) samples from controls (p<0.0001: dF=1; ?2=16.37). A statistical significant difference in terms of HR-HPV frequency between high-grade and low-grade urothelial bladder cancer, was found (p=0.032; RR=0.52-95% CI 0.27-0.93; OR=0.34-95% CI 0.13-0.90). In conclusion, this study highlights the correlation between urothelial bladder cancer and high-risk type HPV infection, suggesting the potential etiopathogenetic role of HR-HPV in urothelial bladder cancer development.lld:pubmed
pubmed-article:21152875pubmed:languageenglld:pubmed
pubmed-article:21152875pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21152875pubmed:citationSubsetIMlld:pubmed
pubmed-article:21152875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21152875pubmed:statusMEDLINElld:pubmed
pubmed-article:21152875pubmed:monthFeblld:pubmed
pubmed-article:21152875pubmed:issn1791-2431lld:pubmed
pubmed-article:21152875pubmed:authorpubmed-author:GeppettiPiera...lld:pubmed
pubmed-article:21152875pubmed:authorpubmed-author:BartolettiRic...lld:pubmed
pubmed-article:21152875pubmed:authorpubmed-author:NesiGabriella...lld:pubmed
pubmed-article:21152875pubmed:authorpubmed-author:MalossiniGian...lld:pubmed
pubmed-article:21152875pubmed:authorpubmed-author:MeacciFrances...lld:pubmed
pubmed-article:21152875pubmed:authorpubmed-author:CaiTommasoTlld:pubmed
pubmed-article:21152875pubmed:authorpubmed-author:MazzoliSandra...lld:pubmed
pubmed-article:21152875pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21152875pubmed:volume25lld:pubmed
pubmed-article:21152875pubmed:ownerNLMlld:pubmed
pubmed-article:21152875pubmed:authorsCompleteYlld:pubmed
pubmed-article:21152875pubmed:pagination485-9lld:pubmed
pubmed-article:21152875pubmed:meshHeadingpubmed-meshheading:21152875...lld:pubmed
pubmed-article:21152875pubmed:meshHeadingpubmed-meshheading:21152875...lld:pubmed
pubmed-article:21152875pubmed:meshHeadingpubmed-meshheading:21152875...lld:pubmed
pubmed-article:21152875pubmed:meshHeadingpubmed-meshheading:21152875...lld:pubmed
pubmed-article:21152875pubmed:meshHeadingpubmed-meshheading:21152875...lld:pubmed
pubmed-article:21152875pubmed:meshHeadingpubmed-meshheading:21152875...lld:pubmed
pubmed-article:21152875pubmed:meshHeadingpubmed-meshheading:21152875...lld:pubmed
pubmed-article:21152875pubmed:meshHeadingpubmed-meshheading:21152875...lld:pubmed
pubmed-article:21152875pubmed:meshHeadingpubmed-meshheading:21152875...lld:pubmed
pubmed-article:21152875pubmed:meshHeadingpubmed-meshheading:21152875...lld:pubmed
pubmed-article:21152875pubmed:meshHeadingpubmed-meshheading:21152875...lld:pubmed
pubmed-article:21152875pubmed:meshHeadingpubmed-meshheading:21152875...lld:pubmed
pubmed-article:21152875pubmed:meshHeadingpubmed-meshheading:21152875...lld:pubmed
pubmed-article:21152875pubmed:meshHeadingpubmed-meshheading:21152875...lld:pubmed
pubmed-article:21152875pubmed:meshHeadingpubmed-meshheading:21152875...lld:pubmed
pubmed-article:21152875pubmed:meshHeadingpubmed-meshheading:21152875...lld:pubmed
pubmed-article:21152875pubmed:year2011lld:pubmed
pubmed-article:21152875pubmed:articleTitleHuman papillomavirus and non-muscle invasive urothelial bladder cancer: potential relationship from a pilot study.lld:pubmed
pubmed-article:21152875pubmed:affiliationDepartment of Urology, Santa Chiara Hospital, Largo Medaglie d'Oro 9, Trento, Italy. ktommy@libero.itlld:pubmed
pubmed-article:21152875pubmed:publicationTypeJournal Articlelld:pubmed